Well of course that's what it was. This announcement wasn't from the NIH, it was a paid PRNewswire from your buddy Bill "rez-vair-ah-trawl" Sardi.
I was wondering about that. I started the thread because Sardi announced a week or two ago on a doctor's health podcast that there was going to be a big announcement Feb 25th at the NIH. It looks like there was some presentation there, though.
Uncle Bill... I mean... Mr. Sardi's own press release looked like half interesting info, half advertisement, but the PRNewswire looks like it could be an ad, yet I don't see where except at the end as it claims only one brand was effective. That didn't seem right.
So what parts of the article hold up? Is the Advanced Cardiology Institute some kind of front? They look like such nice people in their pic... They have a map, so they must be legit.
How does this work? The article starts:
"In a presentation at a National Institutes of Health symposium in Washington DC today, University of Connecticut researchers showed resveratrol limits damage caused by a heart attack, prevents sudden cardiac death in animals, and is "the
best yet devised method of cardioprotection." (The italyics make it seem like an ad)
But that actually took place, right?
Yet this statement on dosage...
"Howard Rothman, senior cardiologist at Advanced Cardiology Institute, warns resveratrol supplement users that the pre-conditioning effect of resveratrol is achieved at a dose ranging from 175-350 milligrams and higher doses may actually be counterproductive. "
... is just Rothman's opinion, or is it a recommendation based on Das' work.
At any rate, do you buy the 175-350mg range?
Edited by cider, 27 February 2010 - 07:06 AM.